Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Victoria E. Walker-Sperling"'
Autor:
Frederick J. Goodson-Gregg, Brian Rothbard, Amy Zhang, Paul W. Wright, Hongchuan Li, Victoria E. Walker-Sperling, Mary Carrington, Stephen K. Anderson
Publikováno v:
Frontiers in Immunology, Vol 10 (2020)
A complex system regulating HLA-C expression in NK cells, driven by an NK-specific promoter that produces alternatively spliced variants of the 5′-UTR has been recently identified. Exon content of the NK-specific 5′-UTR varies strikingly across H
Externí odkaz:
https://doaj.org/article/c925690f8eae457d8eb7c8f9a6010fae
Autor:
Victoria E. Walker-Sperling, Christopher W. Pohlmeyer, Rebecca T. Veenhuis, Megan May, Krystle A. Luna, Allison R. Kirkpatrick, Oliver Laeyendecker, Andrea L. Cox, Mary Carrington, Justin R. Bailey, Roberto C. Arduino, Joel N. Blankson
Publikováno v:
EBioMedicine, Vol 16, Iss C, Pp 141-149 (2017)
HIV-1 controllers are patients who control HIV-1 viral replication without antiretroviral therapy. Control is achieved very early in the course of infection, but the mechanisms through which viral replication is restricted are not fully understood. W
Externí odkaz:
https://doaj.org/article/4bcb4dce63f34ae68fa3f385af3c8e76
Publikováno v:
EBioMedicine, Vol 8, Iss C, Pp 217-229 (2016)
Shock and kill strategies involving the use of small molecules to induce viral transcription in resting CD4+ T cells (shock) followed by immune mediated clearance of the reactivated cells (kill), have been proposed as a method of eliminating latently
Externí odkaz:
https://doaj.org/article/c347107d7599456da202ce0112e8706a
Autor:
Weiwei Dai, Fengting Wu, Natalie McMyn, Bicna Song, Victoria E. Walker-Sperling, Joseph Varriale, Hao Zhang, Dan H. Barouch, Janet D. Siliciano, Wei Li, Robert F. Siliciano
Publikováno v:
Sci Transl Med
Reversing HIV-1 latency promotes killing of infected cells and is essential for cure strategies; however, no single latency reversing agent (LRA) or LRA combination have been shown to reduce HIV-1 latent reservoir size in persons living with HIV-1 (P
Autor:
Rebecca T. Veenhuis, Caroline C. Garliss, Yury V. Kuzmichev, Victoria E. Walker-Sperling, Joel N. Blankson, Christopher W. Pohlmeyer
Publikováno v:
Journal of Virus Eradication, Vol 3, Iss 2, Pp 85-89 (2017)
Journal of Virus Eradication
Journal of Virus Eradication
Aims Latently infected resting CD4 T cells represent a major barrier to HIV-1 eradication efforts. The standard assays used for measuring this reservoir induce activation of resting CD4 T cells with either phytohaemagglutinin (PHA) with irradiated fe
Autor:
Mary Carrington, Justin R. Bailey, Andrea L. Cox, Christopher W. Pohlmeyer, Rebecca T. Veenhuis, Krystle A. Luna, Roberto C. Arduino, Joel N. Blankson, Oliver Laeyendecker, Megan May, Allison R. Kirkpatrick, Victoria E. Walker-Sperling
Publikováno v:
EBioMedicine, Vol 16, Iss C, Pp 141-149 (2017)
EBioMedicine
EBioMedicine
HIV-1 controllers are patients who control HIV-1 viral replication without antiretroviral therapy. Control is achieved very early in the course of infection, but the mechanisms through which viral replication is restricted are not fully understood. W
Publikováno v:
EBioMedicine
Scipedia Open Access
Scipedia SL
EBioMedicine, Vol 8, Iss C, Pp 217-229 (2016)
Scipedia Open Access
Scipedia SL
EBioMedicine, Vol 8, Iss C, Pp 217-229 (2016)
Shock and kill strategies involving the use of small molecules to induce viral transcription in resting CD4 + T cells (shock) followed by immune mediated clearance of the reactivated cells (kill), have been proposed as a method of eliminating latentl
Autor:
Allison Lambert, Victoria E. Walker-Sperling, Robert W. Buckheit, Joel N. Blankson, Christian A. Merlo, M. Bradley Drummond, Greg D. Kirk, Patrick M. Tarwater
Publikováno v:
AIDS Research and Human Retroviruses. 32:1097-1099
Macrophages are targets of HIV-1 infection, and control of viral replication within these cells may be an important component of a T-cell-based vaccine. Although several studies have analyzed the ability of CD8+ T cells to inhibit viral replication i
Autor:
Luiz Francisco Pianowski, Joel N. Blankson, Victoria E. Walker-Sperling, Lucio Gama, Kennedy Goldsborough, Abena K. Kwaa
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 5, p e0174516 (2017)
PLoS ONE, Vol 12, Iss 5, p e0174516 (2017)
BACKGROUND Some latency-reversing agents (LRAs) inhibit HIV-specific CD8+ T cell responses. In a prior study of protein kinase C (PKC) agonists, we found that bryostatin-1 inhibited elite controller/suppressor (ES) CD8+ T cell suppressive activity wh
Publikováno v:
Future microbiology. 11